136 related articles for article (PubMed ID: 16783844)
21. Impact of Pretreatment Neutrophil Count on Chemotherapy Administration and Toxicity in Dogs with Lymphoma Treated with CHOP Chemotherapy.
Fournier Q; Serra JC; Handel I; Lawrence J
J Vet Intern Med; 2018 Jan; 32(1):384-393. PubMed ID: 29205493
[TBL] [Abstract][Full Text] [Related]
22. Prophylaxis with levofloxacin: impact on bacterial susceptibility and epidemiology in a hematopoietic stem cell transplant unit.
Lopes LA; Veroneze I; Burgardt CI; Niebel Stier CJ
Rev Bras Hematol Hemoter; 2014; 36(1):35-42. PubMed ID: 24624034
[TBL] [Abstract][Full Text] [Related]
23. [Side effects of tumor pharmacotherapy. What internists should know].
Wollmer E; Neubauer A
Internist (Berl); 2011 Dec; 52(12):1429-45; quiz 1446. PubMed ID: 22249452
[TBL] [Abstract][Full Text] [Related]
24. Impact of early versus later fluoroquinolone treatment on the clinical; microbiological and resistance outcomes in a mouse-lung model of Pasteurella multocida infection.
Ferran AA; Toutain PL; Bousquet-Mélou A
Vet Microbiol; 2011 Mar; 148(2-4):292-7. PubMed ID: 20888712
[TBL] [Abstract][Full Text] [Related]
25. Antibiotic prophylaxis during chemotherapy-induced neutropenia for patients with acute leukemia.
Hammond SP; Baden LR
Curr Hematol Malig Rep; 2007 May; 2(2):97-103. PubMed ID: 20425357
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of PCR analysis of bacteria and fungi from blood in empiric-therapy-resistant febrile neutropenia.
Nakamura A; Sugimoto Y; Ohishi K; Sugawara Y; Fujieda A; Monma F; Suzuki K; Masuya M; Nakase K; Matsushima Y; Wada H; Katayama N; Nobori T
J Clin Microbiol; 2010 Jun; 48(6):2030-6. PubMed ID: 20392911
[TBL] [Abstract][Full Text] [Related]
27. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.
Cullen M; Steven N; Billingham L; Gaunt C; Hastings M; Simmonds P; Stuart N; Rea D; Bower M; Fernando I; Huddart R; Gollins S; Stanley A;
N Engl J Med; 2005 Sep; 353(10):988-98. PubMed ID: 16148284
[TBL] [Abstract][Full Text] [Related]
28. Rational selection of patients for antibacterial prophylaxis after chemotherapy.
Cullen MH; Billingham LJ; Gaunt CH; Steven NM
J Clin Oncol; 2007 Oct; 25(30):4821-8. PubMed ID: 17947731
[TBL] [Abstract][Full Text] [Related]
29. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
Bucaneve G; Micozzi A; Menichetti F; Martino P; Dionisi MS; Martinelli G; Allione B; D'Antonio D; Buelli M; Nosari AM; Cilloni D; Zuffa E; Cantaffa R; Specchia G; Amadori S; Fabbiano F; Deliliers GL; Lauria F; Foà R; Del Favero A;
N Engl J Med; 2005 Sep; 353(10):977-87. PubMed ID: 16148283
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
Leibovici L; Paul M; Cullen M; Bucaneve G; Gafter-Gvili A; Fraser A; Kern WV
Cancer; 2006 Oct; 107(8):1743-51. PubMed ID: 16977651
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic prophylaxis in chemotherapy-induced neutropenia: time to reconsider.
Lo N; Cullen M
Hematol Oncol; 2006 Sep; 24(3):120-5. PubMed ID: 16783844
[TBL] [Abstract][Full Text] [Related]
32. The prevention of febrile neutropenia.
Pascoe J; Cullen M
Curr Opin Oncol; 2006 Jul; 18(4):325-9. PubMed ID: 16721125
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
